May 11, 2016
Feedback is invited from investigators in academia, industry, health care professionals, patient advocates and health advocacy organizations, scientific or professional organizations, federal agencies, and other interested constituents and the community [regarding] possible future directions to maximize benefits of investments in HIV/AIDS research. Click here for more information.